RBC Bin Hendrix Capital Lifting The target price on CVS Health (CVS) to $ 74 out of $ 58 and remains a rating that exceeds the stocks. The company exceeds its departments with the preparation departments for the year 2025 before expectations with the expression of the MA-MARGIN Recovery, and the analyst also informs the investors in a research note. It seems that the use of MA has settled, which, along with the disciplined pricing, can lead the bullish trend to unanimity estimates in the years out, adds RBC.
-
Take advantage of the smart result of Tipranks, which is a data -based tool to help you discover the highest performance and take informed investment decisions.
-
Watch your stock choices and compare them with Wall Street analytical recommendations with your smart wallet
First published on Thefly -The final source of the actual time, the financial financial news in the market. Try now >>
See hot stocks for those familiar with Tipranks >>
Read more about CVs: